ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces Publication on VEGF- C and D
|
|
willxue123
|
4 |
1.9K |
1 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
4
|
1.9K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
OPT opening price post-CR
|
|
willxue123
|
39 |
14K |
0 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
39
|
14K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
AVH TA
|
|
willxue123
|
15 |
6.2K |
2 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
15
|
6.2K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
AVH TA
|
|
willxue123
|
15 |
6.2K |
1 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
15
|
6.2K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q1 2024 Investor Presentation
|
|
willxue123
|
43 |
17K |
0 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
43
|
17K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Updated Insider Trading & Securities Dealing Policy
|
|
willxue123
|
4 |
1.4K |
2 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
4
|
1.4K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Placement & Institutional Entitlement Offer
|
|
willxue123
|
66 |
23K |
5 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
66
|
23K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
ReCell Go Is Massive
|
|
willxue123
|
161 |
56K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
161
|
56K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Opthea Chart
|
|
willxue123
|
309 |
172K |
3 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
309
|
172K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
willxue123
|
61 |
21K |
1 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
61
|
21K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
willxue123
|
61 |
21K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
61
|
21K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Corporate Presentation - March 2024
|
|
willxue123
|
40 |
16K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
40
|
16K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Enrollment in First Trial of Sozinibercept
|
|
willxue123
|
21 |
8.2K |
0 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
21
|
8.2K
|
0
|
|
ASX - By Stock
|
NAN |
Re:
Ann: H1 FY24 trading update and expectations for FY24
|
|
willxue123
|
58 |
37K |
0 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
58
|
37K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
willxue123
|
372 |
142K |
2 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
372
|
142K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
willxue123
|
372 |
142K |
4 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
372
|
142K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Updates Full Year 2023 Guidance
|
|
willxue123
|
45 |
16K |
1 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
45
|
16K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Why AVH is a bargain right now / chart
|
|
willxue123
|
127 |
63K |
3 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
127
|
63K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Announces European Distribution Partner
|
|
willxue123
|
37 |
11K |
2 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
37
|
11K
|
2
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Quarterly Activities Webinar Presentation - Sep 2023 Qtr
|
|
willxue123
|
7 |
5.1K |
0 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
7
|
5.1K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Successful completion of Share Purchase Plan & US Offer
|
|
willxue123
|
13 |
5.8K |
3 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
13
|
5.8K
|
3
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Becoming a substantial holder
|
|
willxue123
|
3 |
1.3K |
2 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
3
|
1.3K
|
2
|
|
ASX - By Stock
|
NXS |
Re:
High Volume today but why ?
|
|
willxue123
|
11 |
4.0K |
2 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
11
|
4.0K
|
2
|
|
ASX - By Stock
|
NXS |
Re:
High Volume today but why ?
|
|
willxue123
|
11 |
4.0K |
4 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
11
|
4.0K
|
4
|
|
ASX - By Stock
|
NXS |
Re:
High Volume today but why ?
|
|
willxue123
|
11 |
4.0K |
2 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
11
|
4.0K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Annual Report 2023
|
|
willxue123
|
17 |
6.6K |
1 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
17
|
6.6K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Notice under section 708A(5)(e) of the Corporations Act
|
|
willxue123
|
21 |
7.2K |
0 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
21
|
7.2K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Trading Halt
|
|
willxue123
|
14 |
6.9K |
3 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
14
|
6.9K
|
3
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Trading Halt
|
|
willxue123
|
14 |
6.9K |
4 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
14
|
6.9K
|
4
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Trading Halt
|
|
willxue123
|
14 |
6.9K |
1 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
14
|
6.9K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Investor Presentation
|
|
willxue123
|
5 |
1.9K |
0 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
5
|
1.9K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
willxue123
|
161 |
78K |
0 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
161
|
78K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
willxue123
|
3.1K |
824K |
1 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
3.1K
|
824K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Glaucoma Sales update
|
|
willxue123
|
22 |
6.3K |
3 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
22
|
6.3K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
willxue123
|
161 |
78K |
2 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
161
|
78K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Glaucoma Sales update
|
|
willxue123
|
22 |
6.3K |
0 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
22
|
6.3K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
willxue123
|
3.1K |
824K |
3 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
3.1K
|
824K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
$10 by Xmas 2021
|
|
willxue123
|
481 |
226K |
6 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
481
|
226K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: OPT Announces Sozinibercept as the Drug Name for OPT 302
|
|
willxue123
|
3 |
1.8K |
3 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
3
|
1.8K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
willxue123
|
3.4K |
1.2M |
10 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
10
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Submits FDA PMA Supplement for RECELL GO
|
|
willxue123
|
18 |
6.1K |
2 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
18
|
6.1K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Submits FDA PMA Supplement for RECELL GO
|
|
willxue123
|
18 |
6.1K |
3 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
18
|
6.1K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Receives FDA Approval for Full-Thickness Skin
|
|
willxue123
|
127 |
43K |
2 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
127
|
43K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Receives FDA Approval for Full-Thickness Skin
|
|
willxue123
|
127 |
43K |
0 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
127
|
43K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
willxue123
|
233 |
85K |
5 |
17/06/23 |
17/06/23 |
ASX - By Stock
|
233
|
85K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
willxue123
|
233 |
85K |
9 |
17/06/23 |
17/06/23 |
ASX - By Stock
|
233
|
85K
|
9
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Receives FDA Approval for Full-Thickness Skin
|
|
willxue123
|
127 |
43K |
3 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
127
|
43K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Receives FDA Approval for Full-Thickness Skin
|
|
willxue123
|
127 |
43K |
9 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
127
|
43K
|
9
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Receives FDA Approval for Full-Thickness Skin
|
|
willxue123
|
127 |
43K |
9 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
127
|
43K
|
9
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
willxue123
|
233 |
85K |
2 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
233
|
85K
|
2
|
|